Implantable cardioverter-defibrillator
OtherCollection of clinical, biological, hemodynamic and rhythmic data
NCT Number: NCT02873169
Determination of risk factors of ventricular arrhythmias (VAs) after implantation of continuous flow left ventricular assist device in order to characterize which patient requires ICD implantation in primary prevention.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
CHU de Bordeaux, Bordeaux, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Collection of clinical, biological, hemodynamic and rhythmic data
Time frame: 30 days
Clinical, biological, hemodynamic and rhythmic data
Time frame: 30 days
Time frame: 30 days
Rennes University Hospital
Other
Interest of Implantable Cardioverter-defibrillator in Primary Prevention in Patient With Continuous Flow Left Ventricular Assist Device (CF-LVAD)
Acronym: ASSIST-ICD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04133844
Cardiovascular Diseases, Heart Diseases
Rennes, France
View Trial DetailsNCT03446651
Cardiovascular Diseases, Heart Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT05806606
Behavior, Cardiovascular Diseases
Hong Kong
View Trial DetailsNCT06847438
Cardiovascular Diseases, Heart Diseases
Atlanta, Georgia, United States
View Trial Details